CoronaVac is a so-called inactivated vaccine developed by Sinovac Biotech. Unal announced the initial results following randomized trials involving ...
News
- Turkish official says CoronaVac vaccine 91.25% effective
- The Latest: Over 1M passengers screened for flights in US
CoronaVac is a so-called inactivated vaccine developed by Sinovac Biotech. Dr. Serhat Unal announced the initial results Thursday following ...
- How Data and AI Will Keep Your Customers Happy and Engaged
Using AI in this context offers better returns on investment for pharmaceutical, medtech, biotech and CRO organizations creating a unique customer ...
- Greenwich LifeSciences: Optimism On 'GP2' Breast Cancer Immunotherapy Candidate
(GLSI) is clinical-stage biotech focused on the development of its 'GP2' immunotherapy to prevent recurrences of breast cancer as a post-surgical ...
- Canada authorizes second vaccine to fight the pandemic
Health Canada said the vaccine from U.S. biotech firm Moderna is safe for use in the country and Moderna said it anticipates starting shipments to ...